Aemetis, Inc. (NASDAQ:AMTX) is a key player in the biofuels industry, focusing on the production of renewable fuels and chemicals. On March 12, 2026, Loop Capital Markets set a price target of $1.75 for AMTX. At that time, the stock was priced at $1.71, suggesting a potential increase of about 2.04% to reach the target.
Despite a quarterly loss of $0.24 per share, Aemetis outperformed the Zacks Consensus Estimate of a $0.27 loss. This represents an improvement from the previous year's $0.36 per share loss. The earnings report resulted in a positive surprise of 11.11%, showcasing the company's efforts to improve its financial performance.
However, Aemetis reported revenues of $43.31 million for the quarter ending December 2025, which fell short of the Zacks Consensus Estimate by 37.6%. This was also a decline from the $47 million reported in the previous year. Over the past four quarters, Aemetis has consistently missed revenue estimates, highlighting challenges in meeting market expectations.
The stock price of AMTX has seen a significant increase of 21.10%, rising by $0.33 to $1.87. During the day, the stock fluctuated between a low of $1.49 and a high of $1.88. Over the past year, AMTX has experienced a high of $3.66 and a low of $1.22, reflecting its volatility in the market.
With a market capitalization of approximately $123.5 million and a trading volume of 2,084,075 shares, Aemetis remains a notable player in the biofuels industry. Despite challenges in revenue performance, the company's stock has shown resilience, as highlighted by its recent price movements.
